Patents by Inventor Keith A. Moulton
Keith A. Moulton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240153229Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.Type: ApplicationFiled: May 1, 2023Publication date: May 9, 2024Applicant: ELUCID BIOIMAGING INC.Inventors: Andrew J. BUCKLER, Kjell JOHNSON, Xiaonan MA, Keith A. MOULTON, Mark A. BUCKLER, Vladimir VALTCHINOV, David S. PAIK
-
Publication number: 20240093138Abstract: Aspects of the present invention relate to an automated cell culture instrument and to methods for operating such an instrument. In one aspect, the cell culture instrument includes a computing unit and a plurality of electrically controllable resources (e.g., sensors, actuators, etc.). The computing unit receives a protocol, schedules the resources so as to execute the protocol, and operates the resources as scheduled or in response to so as to provide an improved environment for cell culture growth. The computing unit may simulate protocol execution in connection with the scheduling or execution of the protocol.Type: ApplicationFiled: November 16, 2023Publication date: March 21, 2024Inventors: Howard Cannon, Keith Moulton
-
Publication number: 20240078672Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.Type: ApplicationFiled: November 8, 2023Publication date: March 7, 2024Applicant: ELUCID BIOIMAGING INC.Inventors: Andrew J. BUCKLER, Kjell JOHNSON, Xiaonan MA, Keith A. MOULTON, David S. PAIK
-
Publication number: 20240078671Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.Type: ApplicationFiled: November 8, 2023Publication date: March 7, 2024Applicant: ELUCID BIOIMAGING INC.Inventors: Andrew J. BUCKLER, Kjell JOHNSON, Xiaonan MA, Keith A. MOULTON, David S. PAIK
-
Publication number: 20240078673Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.Type: ApplicationFiled: November 8, 2023Publication date: March 7, 2024Applicant: ELUCID BIOIMAGING INC.Inventors: Andrew J. BUCKLER, Kjell JOHNSON, Xiaonan MA, Keith A. MOULTON, David S. PAIK
-
Patent number: 11884913Abstract: Aspects of the present invention relate to an automated cell culture instrument and to methods for operating such an instrument. In one aspect, the cell culture instrument includes a computing unit and a plurality of electrically controllable resources (e.g., sensors, actuators, etc.). The computing unit receives a protocol, schedules the resources so as to execute the protocol, and operates the resources as scheduled or in response to so as to provide an improved environment for cell culture growth. The computing unit may simulate protocol execution in connection with the scheduling or execution of the protocol.Type: GrantFiled: May 11, 2021Date of Patent: January 30, 2024Assignee: Thrive Bioscience, Inc.Inventors: Howard Cannon, Keith Moulton
-
Publication number: 20230326166Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.Type: ApplicationFiled: April 26, 2023Publication date: October 12, 2023Applicant: ELUCID BIOIMAGING INC.Inventors: Andrew J. BUCKLER, Kjell JOHNSON, Xiaonan MA, Keith A. MOULTON, David S. PAIK
-
Publication number: 20230237759Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.Type: ApplicationFiled: February 8, 2023Publication date: July 27, 2023Applicant: ELUCID BIOIMAGING INC.Inventors: Andrew J. BUCKLER, Kjell JOHNSON, Xiaonan MA, Keith A. MOULTON, Mark A. BUCKLER, Vladimir VALTCHINOV, David S. PAIK
-
Patent number: 11676359Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.Type: GrantFiled: May 24, 2021Date of Patent: June 13, 2023Assignee: ELUCID BIOIMAGING INC.Inventors: Andrew J. Buckler, Kjell Johnson, Xiaonan Ma, Keith A. Moulton, Mark A. Buckler, Vladimir Valtchinov, David S. Paik
-
Patent number: 11607179Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.Type: GrantFiled: May 24, 2021Date of Patent: March 21, 2023Assignee: ELUCID BIOIMAGING INC.Inventors: Andrew J. Buckler, Kjell Johnson, Xiaonan Ma, Keith A. Moulton, Mark A. Buckler, Vladimir Valtchinov, David S. Paik
-
Publication number: 20210390689Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.Type: ApplicationFiled: May 24, 2021Publication date: December 16, 2021Applicant: ELUCID BIOIMAGING INCInventors: Andrew J. BUCKLER, Kjell JOHNSON, Xiaonan MA, Keith A. MOULTON, Mark A. BUCKLER, Vladimir VALTCHINOV, David S. PAIK
-
Publication number: 20210282719Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.Type: ApplicationFiled: May 24, 2021Publication date: September 16, 2021Applicant: ELUCID BIOIMAGING INC.Inventors: Andrew J. BUCKLER, Kjell JOHNSON, Xiaonan MA, Keith A. MOULTON, Mark A. BUCKLER, Vladimir VALTCHINOV, David S. PAIK
-
Patent number: 11120312Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.Type: GrantFiled: November 28, 2018Date of Patent: September 14, 2021Assignee: ELUCID BIOIMAGING INC.Inventors: Andrew J. Buckler, Kjell Johnson, Xiaonan Ma, Keith A. Moulton, Mark A. Buckler, Vladimir Valtchinov, David S. Paik
-
Patent number: 11113812Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.Type: GrantFiled: November 28, 2018Date of Patent: September 7, 2021Assignee: ELUCID BIOIMAGING INC.Inventors: Andrew J. Buckler, Kjell Johnson, Xiaonan Ma, Keith A. Moulton, Mark A. Buckler, Vladimir Valtchinov, David S. Paik
-
Publication number: 20210261905Abstract: Aspects of the present invention relate to an automated cell culture instrument and to methods for operating such an instrument. In one aspect, the cell culture instrument includes a computing unit and a plurality of electrically controllable resources (e.g., sensors, actuators, etc.). The computing unit receives a protocol, schedules the resources so as to execute the protocol, and operates the resources as scheduled or in response to so as to provide an improved environment for cell culture growth. The computing unit may simulate protocol execution in connection with the scheduling or execution of the protocol.Type: ApplicationFiled: May 11, 2021Publication date: August 26, 2021Inventors: Howard Cannon, Keith Moulton
-
Patent number: 11094058Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.Type: GrantFiled: November 28, 2018Date of Patent: August 17, 2021Assignee: ELUCID BIOIMAGING INC.Inventors: Andrew J. Buckler, Kjell Johnson, Xiaonan Ma, Keith A. Moulton, Mark A. Buckler, Vladimir Valtchinov, David S. Paik
-
Patent number: 11087459Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.Type: GrantFiled: November 28, 2018Date of Patent: August 10, 2021Assignee: ELUCID BIOIMAGING INC.Inventors: Andrew J. Buckler, Kjell Johnson, Xiaonan Ma, Keith A. Moulton, Mark A. Buckler, Vladimir Valtchinov, David S. Paik
-
Patent number: 11087460Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.Type: GrantFiled: November 30, 2018Date of Patent: August 10, 2021Assignee: ELUCID BIOIMAGING INC.Inventors: Andrew J. Buckler, Kjell Johnson, Xiaonan Ma, Keith A. Moulton, Mark A. Buckler, Vladimir Valtchinov, David S. Paik
-
Patent number: 11071501Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.Type: GrantFiled: November 28, 2018Date of Patent: July 27, 2021Assignee: ELUCID BIOIWAGING INC.Inventors: Andrew J. Buckler, Kjell Johnson, Xiaonan Ma, Keith A. Moulton, Mark A. Buckler, Vladimir Valtchinov, David S. Paik
-
Patent number: 11034929Abstract: Aspects of the present invention relate to an automated cell culture instrument and to methods for operating such an instrument. In one aspect, the cell culture instrument includes a computing unit and a plurality of electrically controllable resources (e.g., sensors, actuators, etc.). The computing unit receives a protocol, schedules the resources so as to execute the protocol, and operates the resources as scheduled or in response to so as to provide an improved environment for cell culture growth. The computing unit may simulate protocol execution in connection with the scheduling or execution of the protocol.Type: GrantFiled: November 18, 2016Date of Patent: June 15, 2021Assignee: Thrive Bioscience, Inc.Inventors: Howard Cannon, Keith Moulton